Nebula Research & Development LLC Prestige Consumer Healthcare Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 3,592 shares of PBH stock, worth $282,762. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,592Holding current value
$282,762% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding PBH
# of Institutions
338Shares Held
50.2MCall Options Held
6.3KPut Options Held
0-
Black Rock Inc. New York, NY8.28MShares$651 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$447 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.96MShares$233 Million0.05% of portfolio
-
Ariel Investments, LLC Chicago, IL2.78MShares$219 Million2.25% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$211 Million0.21% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $3.92B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...